Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current combined vaccines with hepatitis B

G Papaevangelou1

  • 1University of Athens, Faculty of Nursing, Greece.

Vaccine
|January 23, 1999
PubMed
Summary

Combining the Hepatitis B (HB) vaccine with other childhood vaccines simplifies administration and improves delivery logistics. These combination vaccines are expected to increase vaccine acceptance and coverage rates globally.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decline of hepatitis B infection in Greece.

European journal of epidemiology·1999
Same author

Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

European journal of epidemiology·1999
Same author

Hepatitis B maternal-fetal transmission in Southern Europe.

Intervirology·1999
Same author

Hepatitis B immunization programme: lessons learnt in Greece.

Vaccine·1999
Same author

Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.

Vaccine·1997
Same author

Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule.

Vaccine·1995

Area of Science:

  • Immunology
  • Public Health
  • Vaccinology

Background:

  • Hepatitis B (HB) vaccine is part of national immunization programs in over 90 countries.
  • Combining vaccines can reduce costs, simplify administration, and enhance vaccine delivery logistics.
  • Combination vaccines are anticipated to improve vaccine acceptance and coverage rates.

Purpose of the Study:

  • To review the development and implications of combined vaccines including Hepatitis B (HB).
  • To assess the potential benefits of combined vaccine formulations on immunization programs.
  • To highlight the need for further research into optimized vaccination schedules.

Main Methods:

  • Review of existing literature on combined vaccine formulations.
  • Analysis of the impact of combined vaccines on administration and logistics.
  • Evaluation of immunogenicity and reactogenicity data for combined vaccines.

Main Results:

  • Several combined vaccines (DTP + HB, DT + HB, HA + HB, HB + Hib) are already in use.
  • Further combined vaccines (DTP + HB + IPV, DTP + HB + IPV + Hib) are under development.
  • The immunogenicity and reactogenicity of individual vaccine components are expected to remain consistent in combination.

Conclusions:

  • Combined vaccines offer significant advantages for immunization programs.
  • Further research is needed to tailor vaccination schedules to specific regional epidemiological needs.
  • Combination vaccines are a promising strategy to improve global public health outcomes through increased vaccine coverage.

Related Experiment Videos